Barone Francesca 4
4 · Candel Therapeutics, Inc. · Filed May 2, 2023
Insider Transaction Report
Form 4
Barone Francesca
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Biuy)
2023-04-28+90,000→ 90,000 totalExercise: $1.29Exp: 2033-04-28→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following April 28, 2023, subject to the Reporting Person's continued service on each vesting date.